InterCept Inc Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (44)

Latest Posts

About This Stock More About This Stock
Oppenheimer Downgrades Intercept Despite Two-Day Share Collapse
Article By: The Fly
Friday, September 22, 2017 2:23 PM EST
Oppenheimer analyst Jay Olson downgraded this afternoon shares of Intercept Pharmaceuticals to Perform from Outperform.
In this article: ICPT
Read
Technicals Always Don’t Work Out The Way You Would Expect
Article By: Bespoke Investment Group
Friday, September 22, 2017 11:42 AM EST
At the most recent trading day shown, the stock broke out above resistance to a new medium-term high. Not only that, but volume on the day of the breakout was also strong, coming in at twice the 50-day moving average.
In this article: ICPT
Read
Citi Calls FDA Communication 'New Negative' For Intercept Shares
Article By: The Fly
Thursday, September 21, 2017 7:45 PM EST
ICPT stock in afternoon trading was down 18%.
In this article: ICPT
Read
Intercept Slides As Analyst Calls CymaBay Drug 'True Contender' After Data
Article By: The Fly
Monday, July 17, 2017 3:33 PM EST
Shares of Intercept Pharmaceuticals are sliding after H.C. Wainwright analyst Ed Arce raised his price target for its competitor CymaBay Therapeutics following data from the company's Phase 2 study of seladelpar in primary biliary cholangitis.
In this article: ICPT Also: CBAY
Read
Good Day Today: XBI Breaks Through To YTD Highs
Article By: Rod Raynovich
Monday, June 19, 2017 9:31 PM EST
Tech stocks rebounded today and biotech stocks soared and maintained the market lead in 2017 performance.
In this article: BMY, ALNY, BMRN, INCY, QQQ, AMGN, CLVS, GILD, XBI, XLV, ICPT, BLUE, RDUS, IBB
Read

PARTNER HEADLINES

Latest Tweets for $ICPT

No tweets yet!